Tempus AI’s $600 Million Acquisition of Ambry Genetics

Debevoise & Plimpton advised Konica Minolta, Inc. on the transaction, and Cooley advised Tempus AI, Inc.Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here